Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px

Document › Details

Orchard Therapeutics Ltd.. (3/21/19). "Press Release: Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights". Boston, MA & London.

	Organisation	Orchard Therapeutics Ltd.
	Group	Kyowa Kirin (Group)
	Organisation 2	GlaxoSmithKline plc (LSE: GSK, NYSE: GSK)
	Today	GSK plc (LSE: GSK, NYSE: GSK)
	Group	GSK (Group)
	Product	Strimvelis
	Product 2	OTL-102 (Orchard Therapeutics)
	Person	Rothera, Mark (Freeline Therapeutics –202202 CEO before Orchard Therapeutics + PTC Tx + Aegerion + Shire RESIGNED 2/22)
	Person 2	Zheng, Ran (Landmark Bio 202107– CEO before Orchard Therapeutics + Amgen + Diosynth + Genzyme)

Original document
accessed by [iito] on 2019-03-31

Record changed: 2024-08-24

Picture Swiss Biotech Association LSUS Swiss Biotech Days 2025 Basel 650x200px

More documents for Kyowa Kirin (Group)

[1] Annogen B.V.. (6/4/24). "Press Release: Annogen Announces Research Collaboration with Orchard Therapeutics for the Development of CNS-cell Specific Promoters". Amsterdam....
[2] Orchard Therapeutics plc. (1/24/24). "Press Release: Kyowa Kirin Successfully Completes Acquisition of Orchard Therapeutics, a Global Gene Therapy Leader for Rare Diseases". Tokyo, London & Boston, MA....
[3] Orchard Therapeutics plc. (10/5/23). "Press Release: Kyowa Kirin to Acquire Orchard Therapeutics". Tokyo, London & Boston, MA....
[4] Fountain Healthcare Partners. (11/2/20). "Press Release: Fountain Healthcare Partners Announces Final Close of €125 Million for Fund III"....
[5] Oxford Biomedica plc. (3/18/20). "Press Release: Building the Group for Future Growth. Business Update". Oxford....
[6] 4BIO Capital (4BIO Ventures Management Ltd.). (9/9/19). "Press Release: 4BIO Capital Raises $50 million in First Close of New Advanced Therapies Fund". London & Boston, MA....
[7] GlaxoSmithKline plc. (8/23/19). "Press Release: GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple MMyeloma". London....
[8] Orchard Therapeutics Ltd.. (3/27/19). "Press Release: Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD". Boston, MA & London....
[9] Orchard Therapeutics Ltd.. (3/18/19). "Press Release: Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer". Boston, MA & London....
[10] Orchard Therapeutics Ltd.. (3/4/19). "Press Release: Orchard Therapeutics to Present at the Cowen 39th Annual Health Care Conference on March 11, 2019". Boston, MA & London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]